Summary
The Department of Veterans Affairs, through Network Contract Office 8 (Tampa, FL), has issued a Special Notice/RFI for the synthesis of NPC86, a novel cyclic peptide drug being investigated for metabolic diseases such as type 2 diabetes and neurodegenerative conditions. The notice indicates the Government's intent to award a sole-source contract to Curia Global Inc. to produce 2 grams of NPC86 via Solid Phase Peptide Synthesis (SPPS) on Rink amide resin, targeting 95% HPLC purity. Responses and any manufacturer authorization letters are due by July 28, 2026 at 10:00 AM EDT, with a period of performance from August 17, 2026 through August 16, 2027.